IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 121 filers reported holding IVERIC BIO INC in Q2 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $5,171,400 | -24.2% | 131,454 | -53.1% | 3.50% | -30.3% |
Q1 2023 | $6,824,565 | -11.6% | 280,500 | -22.2% | 5.03% | +5.9% |
Q4 2022 | $7,718,305 | -23.7% | 360,500 | -36.0% | 4.75% | +9.1% |
Q3 2022 | $10,111,000 | +86.5% | 563,607 | 0.0% | 4.35% | +44.1% |
Q2 2022 | $5,422,000 | -40.3% | 563,607 | +4.5% | 3.02% | -28.8% |
Q1 2022 | $9,080,000 | +15.6% | 539,500 | +14.8% | 4.24% | +28.4% |
Q4 2021 | $7,858,000 | -57.4% | 470,000 | -58.6% | 3.30% | -49.2% |
Q3 2021 | $18,432,000 | +133.7% | 1,135,000 | -9.2% | 6.50% | +106.3% |
Q2 2021 | $7,888,000 | -19.2% | 1,250,000 | -20.8% | 3.15% | -10.4% |
Q1 2021 | $9,759,000 | +16.5% | 1,579,093 | +30.2% | 3.52% | +54.3% |
Q4 2020 | $8,378,000 | +85.1% | 1,212,500 | +51.1% | 2.28% | +85.5% |
Q3 2020 | $4,526,000 | +29.1% | 802,500 | +16.7% | 1.23% | +21.3% |
Q2 2020 | $3,506,000 | +633.5% | 687,500 | +394.6% | 1.01% | +336.6% |
Q1 2020 | $478,000 | -93.9% | 139,000 | -84.7% | 0.23% | -88.0% |
Q4 2019 | $7,808,000 | – | 910,000 | – | 1.93% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |